Abstract 5525: An Fc-competent bispecific antibody targeting PD-L1 and TIGIT induces strong immune responses and potent anti-tumor efficacy

提吉特 抗体 免疫系统 癌症研究 T细胞 流式细胞术 CD8型 免疫学 化学 生物
作者
Shuang Dai,Wei-Feng Huang,Zhijun Yuan,Shaogang Peng,Jiayi Si,Chao Wang,Yan Yao,Xiaoniu Miao,Yingda Xu,Joanne Sun,Xiaolin Liu,Andy Tsun,Tianhang Zhai
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:82 (12_Supplement): 5525-5525 被引量:3
标识
DOI:10.1158/1538-7445.am2022-5525
摘要

Abstract Background: TIGIT (T-cell immunoglobulin and ITIM domain), which is primarily expressed on activated and 'exhausted' T and NK cells, is one of the most promising 'next generation' immune checkpoint target. Engagement of TIGIT to its ligands (i.e., PVR and PVRL2) leads to inhibitory signaling in T cells and promotes the functional exhaustion of tumor-infiltrating T lymphocytes. Anti-TIGIT monoclonal antibodies have shown clinical benefit when combined with anti-PD-L1 agents in NSCLC. Here, we describe our novel anti-PD-L1 × TIGIT bispecific antibody (PD-L1 × TIGIT biAb) that blocks both the PD-L1/PD-1 and TIGIT/PVR/PVRL2 pathways and has the potential to exhibit equal clinical benefit compared to current combination therapies. Methods: PD-L1 × TIGIT biAb was engineered with a fully-human IgG targeting TIGIT in a g1-Fc backbone, fused to a VHH at the C-terminus targeting PD-L1. Binding affinities and specificity testing were studied by flow cytometry and biolayer interferometry. The co-binding of the PD-L1 × TIGIT biAb to TIGIT and PD-L1 was detected by ELISA. The immunomodulatory functions of the PD-L1 × TIGIT biAb were evaluated using luciferase reporter cell assays and mixed lymphocyte reaction (MLR) assays in vitro, and human PBMC models in vivo. Results: The PD-L1 × TIGIT biAb binds with high affinity to the extracellular domain of human TIGIT and PD-L1 and can bind to TIGIT and PD-L1 simultaneously. In a competition assay, the PD-L1 × TIGIT biAb efficiently blocked the interaction between TIGIT and PVR/PVRRL2, and likewise PD-L1 to PD-1. The PD-L1 × TIGIT biAb induced higher luciferase signals than the anti-TIGIT or anti-PD-L1 mAbs alone in a luciferase reporter-based cell system and enhanced IFN-γ production in an MLR assay. In vivo, the PD-L1 × TIGIT biAb demonstrates similar anti-tumor efficacy to the combination of anti-TIGIT and anti-PD-L1 mAbs, which is stronger than the single-agents alone. We have also completed GLP-toxicity studies that have shown excellent safety. Conclusion: We have discovered a novel PD-L1 × TIGIT biAb, which induces strong immune responses in vitro and in vivo, supporting its clinical development for the treatment of human cancers. Clinical trials shall be initiating in early 2022. Citation Format: Shuang Dai, Weifeng Huang, Zhijun Yuan, Shaogang Peng, Jiayi Si, Chao Wang, Yao Yan, Xiaoniu Miao, Yingda Xu, Joanne Sun, Xiaolin Liu, Andy Tsun, Tianhang Zhai. An Fc-competent bispecific antibody targeting PD-L1 and TIGIT induces strong immune responses and potent anti-tumor efficacy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 5525.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
香蕉觅云应助bestbanana采纳,获得10
刚刚
showmaker完成签到,获得积分10
刚刚
刚刚
1秒前
初彤完成签到,获得积分10
1秒前
1秒前
wentong完成签到,获得积分10
2秒前
哈哈哈哈完成签到 ,获得积分10
2秒前
初彤发布了新的文献求助10
3秒前
Theodore发布了新的文献求助10
4秒前
能干的夏瑶完成签到 ,获得积分10
7秒前
紫米完成签到,获得积分10
7秒前
vagabond完成签到 ,获得积分10
15秒前
赵恶天发布了新的文献求助10
18秒前
迷蝴蝶完成签到,获得积分10
19秒前
www完成签到,获得积分10
20秒前
zzt应助111采纳,获得10
21秒前
囚穆完成签到 ,获得积分10
21秒前
依依完成签到 ,获得积分10
23秒前
30秒前
MZ完成签到,获得积分10
31秒前
赵恶天完成签到,获得积分10
32秒前
一颗辣白菜叶完成签到 ,获得积分10
34秒前
bestbanana发布了新的文献求助10
35秒前
37秒前
Mt完成签到,获得积分10
39秒前
39秒前
无限冰淇淋完成签到,获得积分10
40秒前
这课题真顺利完成签到,获得积分10
40秒前
飞翔的梦完成签到,获得积分10
41秒前
丘比特应助刘大恒采纳,获得10
42秒前
白大褂发布了新的文献求助10
43秒前
天马行空完成签到,获得积分10
44秒前
Wangying完成签到,获得积分10
46秒前
memore完成签到 ,获得积分10
48秒前
jinshijie完成签到 ,获得积分10
48秒前
ding应助bestbanana采纳,获得10
50秒前
忐忑的草丛完成签到,获得积分10
51秒前
集典完成签到 ,获得积分10
51秒前
52秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Defense against predation 800
Very-high-order BVD Schemes Using β-variable THINC Method 568
Chen Hansheng: China’s Last Romantic Revolutionary 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3137067
求助须知:如何正确求助?哪些是违规求助? 2788055
关于积分的说明 7784485
捐赠科研通 2444102
什么是DOI,文献DOI怎么找? 1299733
科研通“疑难数据库(出版商)”最低求助积分说明 625557
版权声明 601010